EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Dynamic Evolution of SARS-CoV-2 in a Patient on Chemotherapy

Weihua Huang, Changhong Yin, Kimberly P Briley, William A B Dalzell, John T Fallon iD

Viruses · 2023

DOI: 10.3390/v15081759 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Viruses, 2023. Verfasst von Weihua Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA. Hauptthemen laut MEDLINE: COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: North Carolina Department of Health and Human Services (NCDHHS), CDC Epidemiology and Laboratory Capacity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved significantly during the pandemic and resulted in daunting numbers of genomic sequences. Tracking SARS-CoV-2 evolution during persistent cases could provide insight into the origins and dynamics of new variants. We report here a case of B-cell acute lymphocytic leukemia on chemotherapy with infection of SARS-CoV-2 for more than two months. Genomic surveillance of his serial SARS-CoV-2-positive specimens revealed two unprecedented large deletions, Δ15–26 and Δ138–145, in the viral spike protein N-terminal domain (NTD) and demonstrated their dynamic shifts in generating these new variants. Located at antigenic supersites, these large deletions are anticipated to dramatically change the spike protein NTD in three-dimensional protein structure prediction, which may lead to immune escape but reduce their viral transmissibility. In summary, we present here a new viral evolutionary trajectory in a patient on chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Leukemia, Lymphocytic, Chronic, B-CellHumansSARS-CoV-2Spike Glycoprotein, CoronavirusGenomics

Stichwörter der Autor:innen

COVID-19SARS-CoV-2chemotherapydeletionevolution

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.
  • Department of Pediatrics, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.

ORCID-Profile: John T Fallon

Förderung

  • North Carolina Department of Health and Human Services (NCDHHS)
  • CDC Epidemiology and Laboratory Capacity

Zitieren

APA

Huang, W., Yin, C., Briley, K. P., Dalzell, W. A. B., & Fallon, J. T. (2023). Dynamic Evolution of SARS-CoV-2 in a Patient on Chemotherapy. Viruses. https://doi.org/10.3390/v15081759

Vancouver

Huang W, Yin C, Briley KP, Dalzell WAB, Fallon JT. Dynamic Evolution of SARS-CoV-2 in a Patient on Chemotherapy. Viruses. 2023. doi:10.3390/v15081759

BibTeX
@article{Huang2023,
  author = {Huang, Weihua and Yin, Changhong and Briley, Kimberly P and Dalzell, William A B and Fallon, John T},
  title = {Dynamic Evolution of SARS-CoV-2 in a Patient on Chemotherapy},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15081759}
}
Kostenlos starten →